Biocompatibility Evaluation of Different Alginates and Alginate-Based Microcapsules
- 25 February 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 6 (2) , 927-931
Abstract
Biocompatibility of biomaterials and biomaterial-based medical devices is a critical issue for the long-term function on multiple therapeutic systems. In the past few years, there has been an increasing interest in producing more biocompatible biomaterials and in developing novel assays to analyze the quality of the products. In this study, a battery of in vitro techniques to assess the biocompatibility of alginates with different compositions and purities and alginate-based microcapsules is presented. Study of the protein and polyphenol content of the alginates revealed clear differences between the nonpurified and the purified alginates. A similar behavior was observed when the mitogenic activity and the tumor necrosis factor-α secretion induced by the alginates were assessed. Interestingly, when the latter two techniques were adapted to evaluate the different alginate microcapsules, a correlation with the results obtained for the alginate samples was observed. These results reinforce the idea of using the full battery of assays here reported to screen alginates and alginate-based microcapsules before implantation.Keywords
This publication has 22 references indexed in Scilit:
- Fourier transform infrared spectroscopy studies of alginate–PLL capsules with varying compositionsJournal of Biomedical Materials Research Part A, 2003
- Cell microencapsulation technology for biomedical purposes: novel insights and challengesTrends in Pharmacological Sciences, 2003
- Visualization of alginate–poly‐L‐lysine–alginate microcapsules by confocal laser scanning microscopyBiotechnology and Bioengineering, 2003
- Tissue responses against immunoisolating alginate‐PLL capsules in the immediate posttransplant periodJournal of Biomedical Materials Research, 2002
- Alginates from wound dressings activate human macrophages to secrete tumour necrosis factor-αBiomaterials, 2000
- Immunocompatibility and biocompatibility of cell delivery systemsAdvanced Drug Delivery Reviews, 2000
- Production of mitogen‐contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresisElectrophoresis, 1992
- Colorimetric assay fop cellular activity in microcapsulesBiomaterials, 1990
- Alginate as immobilization material. II: Determination of polyphenol contaminants by fluorescence spectroscopy, and evaluation of methods for their removalBiotechnology and Bioengineering, 1989
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976